Daily Cosmetic Research Analysis
A mechanistic imaging-modeling framework reveals that dissolved ions, not intact particles, predominantly drive metallic nanoparticle toxicity—informing safer cosmetic nanoformulations. A randomized split-neck trial shows that adding a topical antioxidant serum to fractional microneedle radiofrequency enhances neck rejuvenation outcomes. An animal-free polyamide 6 scaffold enables robust human airway mucosa models for drug/cosmetic toxicity testing with mucociliary differentiation and barrier in
Summary
A mechanistic imaging-modeling framework reveals that dissolved ions, not intact particles, predominantly drive metallic nanoparticle toxicity—informing safer cosmetic nanoformulations. A randomized split-neck trial shows that adding a topical antioxidant serum to fractional microneedle radiofrequency enhances neck rejuvenation outcomes. An animal-free polyamide 6 scaffold enables robust human airway mucosa models for drug/cosmetic toxicity testing with mucociliary differentiation and barrier integrity equivalent to SIS.
Research Themes
- Nanoparticle safety and mechanistic toxicity modeling for cosmetic applications
- Energy-based rejuvenation enhanced by topical antioxidants
- Animal-free advanced tissue models for cosmetic/drug toxicity testing
Selected Articles
1. Differential Mapping of Intracellular Metallic Nanoparticles and Ions and Dynamic Modeling Prediction.
Using dual-modal live-cell imaging plus kinetic modeling, the study quantifies how much toxicity arises from intact metallic nanoparticles versus their dissolved ions. Across Ag, CuO, and ZnO systems (20–100 nm) and 0–100 mg/L exposures, ionic species accounted for the majority of toxicity with distinct material-specific profiles, providing a mechanistic basis to design safer nano-enabled formulations.
Impact: First integrated real-time mapping of nanoparticles and ions with a mechanistic toxicity model that generalizes across commonly used cosmetic-relevant materials (Ag, ZnO). Provides actionable parameters (dissolution and ion contribution) for safety-by-design.
Clinical Implications: Risk assessment for nano-enabled cosmetics should prioritize controlling ionic release (e.g., coatings, particle size, matrix effects). Regulatory toxicology can incorporate ion-dominant mechanisms into exposure limits and formulation guidance.
Key Findings
- 2.68–34.7% of internalized MNPs dissolved intracellularly post-uptake; smaller particles released 1.08–1.22× more ions.
- Ions dominated toxicity: 59.7–79.4% (AgNPs), 69.6–100% (CuO-NPs), 97.7% (ZnO-NPs) across 0–100 mg/L.
- Distinct toxicity shapes by material: Ag biphasic, CuO logistic-like, ZnO entirely ion-driven.
- An integrative model mechanistically linked extracellular dissolution, uptake, intracellular transformation, and toxicity pathways.
Methodological Strengths
- Dual-modal live-cell imaging (AIE confocal + label-free scattering) enabling simultaneous nanoparticle/ion visualization.
- Quantitative kinetic modeling across multiple materials and particle sizes linking spatiotemporal processes to toxicity.
Limitations
- In vitro/cell-based systems; lack of in vivo validation.
- Particle types limited to Ag, CuO, ZnO (20–100 nm) and concentration window 0–100 mg/L.
Future Directions: Validate predictions in organotypic/animal models; extend to coated/composite nanoparticles and consumer-relevant matrices to define dissolution-controlling formulation strategies.
Predicting the toxicity of metallic nanoparticles (MNPs) remains a longstanding challenge in the biomedical field, primarily due to the unresolved dynamic transformation between pristine MNPs and their dissolved ionic counterparts within living systems. Herein, we develop an integrative bioimaging-mathematical framework that quantifies, in real-time mode, the contributions of MNPs and their ionic counterparts to toxicity. By integrating aggregation-induced emission (AIE)-based confocal imaging with label-free scattered light tracking, we achieve simultaneous and noninvasive visualization of different-sized pristine silver, copper oxide, and zinc oxide nanoparticles (Ag-, CuO-, and ZnO-NPs, 20-100 nm) and their ionic forms in living cells. This dual-modal approach reveals size-dependent intracellular dissolution dynamics, with 2.68-34.7% of internalized MNPs dissolving post uptake and smaller particles releasing 1.08-1.22 times more ions than larger particles. Leveraging these spatiotemporal insights, we developed a cascading toxicity model that mechanistically links extracellular dissolution, cellular uptake, intracellular transformation, and toxicity pathways. The model demonstrates that ionic species dominate toxicity across all MNPs, contributing 59.7-79.4% (AgNPs), 69.6-100% (CuO-NPs), and 97.7% (ZnO-NPs) of overall toxicity within 0-100 mg/L. Strikingly, toxicity profiles vary by MNP type: AgNPs exhibit biphasic toxicity, CuO-NPs follow a logistic-like pattern, and ZnO-NPs remain entirely ion-driven. By bridging real-time bioimaging with kinetic modeling, our framework provides the first
2. Fractional microneedle radiofrequency with the application of vitamin C, E, and ferulic acid serum for neck skin rejuvenation: a prospective, double-blinded, split-neck, placebo-controlled trial.
In a double-blind split-neck RCT (n=31), adding a vitamin C/E/ferulic acid serum to FMR produced significantly greater wrinkle reductions and superior GAIS and biophysical improvements versus FMR alone at 12 weeks. Histology showed increased elastin and reduced senescence markers, supporting an adjunctive antioxidant role.
Impact: Provides randomized, blinded evidence that a widely used antioxidant cocktail substantially augments an energy-based neck rejuvenation modality, with clinical and histologic corroboration.
Clinical Implications: Consider incorporating antioxidant serum post-FMR to enhance neck rejuvenation outcomes. Split-neck data support unilateral application protocols and inform patient counseling on expected additive benefits.
Key Findings
- Antioxidant-treated sides showed greater wrinkle reduction at week 12 (29.9% vs 18.0%).
- Improved GAIS scores and biophysical parameters favored the antioxidant side.
- Histology demonstrated increased elastin production and reduced senescence markers with the antioxidant adjunct.
Methodological Strengths
- Prospective randomized double-blind split-neck, placebo-controlled design.
- Multimodal outcomes including clinical scales, biophysical metrics, and histology.
Limitations
- Small single-center sample (n=31) with 12-week follow-up.
- Specific antioxidant formulation; generalizability to other serums or parameters unknown.
Future Directions: Larger multicenter RCTs with longer follow-up and head-to-head comparison of antioxidant formulations; dose-timing optimization and cost-effectiveness analyses.
PURPOSE: To evaluate the efficacy of fractional microneedle radiofrequency (FMR) combined with topical antioxidant serum (vitamin C, E, and ferulic acid) compared to FMR alone for neck rejuvenation. MATERIALS AND METHODS: This prospective, randomized, double-blind, split-neck trial included 31 participants aged 30-65 years with visible signs of neck aging. Subjects underwent two FMR treatments at 4-week intervals. Immediately post-treatment, participants applied antioxidant serum to one randomly assigned side of the neck and placebo to the contralateral side daily. Efficacy was assessed by Fitzpatrick Wrinkle and Elastosis Scale, Global Esthetic Improvement Scale (GAIS), and biophysical skin parameters. Histological analyses evaluated elastin production and markers of senescence. RESULTS: At week 12, the antioxidant-treated neck side showed significantly greater reductions in wrinkle severity (29.9% vs. 18.0%; CONCLUSIONS: Combining FMR with topical antioxidant serum substantially enhances neck skin rejuvenation, demonstrating superior clinical and histological outcomes. This approach effectively addresses neck aging, highlighting antioxidants as valuable adjunctive therapies.
3. Improving Human Respiratory Mucosa Tissue Models with Polyamide 6 Scaffolds.
Electrospun PA6 scaffolds support ECM deposition and full mucociliary differentiation, yielding airway mucosa models with barrier integrity and viral susceptibility comparable to SIS but without animal-derived components. The models express key xenobiotic enzymes, offering reproducible, animal-free platforms for drug and cosmetic toxicity testing.
Impact: Replaces animal-derived scaffolds with a synthetic, reproducible alternative that maintains functionally relevant features, advancing ethical and standardized toxicity testing for cosmetics and drugs.
Clinical Implications: Facilitates standardized, animal-free preclinical testing of inhaled or topical agents, reducing variability and potential confounders from animal-derived matrices.
Key Findings
- PA6 scaffolds supported ECM production by human nasal fibroblasts and full mucociliary differentiation of respiratory epithelium.
- Models exhibited epithelial barrier integrity and influenza A susceptibility comparable to SIS-based constructs.
- Expression of key xenobiotic metabolizing enzymes was maintained, enabling toxicity/metabolism studies.
- Animal-derived materials were eliminated, improving reproducibility and reducing antigen/pathogen interference.
Methodological Strengths
- Direct comparison of PA6 and SIS scaffolds across cellular, functional, and infection-readouts at the air–liquid interface.
- Demonstration of mucociliary differentiation and xenobiotic enzyme expression relevant to toxicity testing.
Limitations
- In vitro model; lacks systemic interactions and in vivo validation.
- Differentiation timelines and donor-to-donor variability not fully detailed.
Future Directions: Scale-up and inter-lab validation; integration with immune/stromal complexity; application to standardized cosmetic/drug toxicity pipelines and regulatory qualification.
Advanced tissue-engineered respiratory models are essential for studying drug or cosmetic toxicity, infection biology and xenobiotic metabolism. Here, we investigated a polyamide 6 (PA6)-based electrospun stromal scaffold as a substitute for porcine-derived small intestinal submucosa (SIS) to build human airway mucosa tissue models at the air-liquid interface. We demonstrate that the porous PA6 scaffold supports extracellular matrix production by human nasal fibroblasts and facilitates the complete differentiation of respiratory epithelial cells to the mucociliary phenotype. These models reduce reliance on animal-derived materials, improve reproducibility, and minimize potential interference from animal-derived antigens and pathogens. Both PA6- and SIS-based models promote fibroblast migration, epithelial differentiation, and the expression of key xenobiotic metabolizing enzymes. They exhibit comparable epithelial barrier integrity and susceptibility to influenza A virus infections. These findings establish PA6 scaffolds as a suitable, animal-free alternative to the SIS to build human airway mucosa tissue models.